Clinical Trial: Two Bupivacaine Concentrations for Erector Spinae Plane Block in Percutaneous Nephrolithotomy

U.S., June 18 -- ClinicalTrials.gov registry received information related to the study (NCT07653230) titled 'Two Bupivacaine Concentrations for Erector Spinae Plane Block in Percutaneous Nephrolithotomy' on June 12.

Brief Summary: People who undergo percutaneous nephrolithotomy (PNL), a procedure used to remove kidney stones, often experience pain after surgery. An ultrasound-guided erector spinae plane block (ESPB) is commonly used to help reduce this pain.

This study compares two different concentrations of bupivacaine, a local anesthetic medication, used during ESPB. Participants undergoing PNL will receive either 0.25% or 0.375% bupivacaine as part of their pain management.

Researchers will compare pain scores, the need for additiona...